Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
World J Microbiol Biotechnol ; 34(3): 45, 2018 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-29520519

RESUMO

Group B streptococcus (GBS) or Streptococcus agalactiae, is an opportunistic pathogen causing a wide range of infections like pneumonia, sepsis, and meningitis in newborn, pregnant women and adults. While this bacterium has adapted well to asymptomatic colonization of adult humans, it still remains a potentially devastating pathogen to susceptible infants. Advances in molecular techniques and refinement of in vitro and in vivo model systems have elucidated key elements of the pathogenic process, from initial attachment to the maternal vaginal epithelium to penetration of the newborn blood-brain barrier. Still, the formidable array of GBS virulence factors makes this bacterium at the forefront of neonatal pathogens. The involvement of bacterial components in the host-pathogen interaction of GBS pathogenesis and its related diseases is not clearly understood. In this study we demonstrated the role of a 39 kDa factor from GBS which plays an important role in the process of its invasion. We found a homogeneous 39 kDa factor from the cytosol of GBS after following a combination of sequential purification steps involving molecular sieving and ion exchange chromatography using ACTA-FPLC system. Its N-terminal sequence showed a homology with xenobiotic response element type transcriptional regulator protein, a 40 kDa protein of Streptococcus. This factor leads to inhibition of GBS invasion in HeLa and A549 cells. This protein also showed sensitivity and specific cross reactivity with the antibodies raised against it in New Zealand white rabbits by western immunoblotting. This inhibitory factor was further confirmed tolerant for its cytotoxicity. These results add a novel aspect to bacterial pathogenesis where bacteria's own intracellular protein component can act as a potential therapeutic candidate by decreasing the severity of disease thus promoting its invasion inhibition.


Assuntos
Proteínas de Bactérias/farmacologia , Citosol/metabolismo , Células Epiteliais/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus agalactiae/patogenicidade , Fatores de Virulência/metabolismo , Células A549 , Animais , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/metabolismo , Feminino , Células HeLa/efeitos dos fármacos , Interações Hospedeiro-Patógeno , Humanos , Coelhos , Elementos Reguladores de Transcrição , Streptococcus agalactiae/genética , Virulência/efeitos dos fármacos , Fatores de Virulência/genética , Fatores de Virulência/isolamento & purificação
2.
Fertil Steril ; 84(5): 1539-41, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16275266

RESUMO

Spermatozoal agglutinating factor (SAF) that agglutinates human spermatozoa has been isolated from Staphylococcus aureus. By scanning electron microscopy, Staphylococcus aureus adherence was observed on sperm tails.


Assuntos
Infertilidade Feminina/microbiologia , Aglutinação Espermática , Espermatozoides/microbiologia , Staphylococcus aureus/isolamento & purificação , Antígenos de Bactérias/isolamento & purificação , Feminino , Humanos , Masculino , Aglutinação Espermática/imunologia , Espermatozoides/citologia , Staphylococcus aureus/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA